Myriad Genetics, Inc (NASDAQ:MYGN) has a beta value of 2.03 and has seen 3.67 million shares traded in the last trading session. The company, currently valued at $391.77M, closed the last trade at $4.25 per share which meant it gained $0.36 on the day or 9.25% during that session. The MYGN stock price is -589.41% off its 52-week high price of $29.30 and 9.18% above the 52-week low of $3.86.
The consensus among analysts is that Myriad Genetics, Inc (MYGN) is Hold stock at the moment, with a recommendation rating of 2.88. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 5 out of 7 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Myriad Genetics, Inc (NASDAQ:MYGN) trade information
Sporting 9.25% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the MYGN stock price touched $4.25 or saw a rise of 45.58%. Year-to-date, Myriad Genetics, Inc shares have moved -69.00%, while the 5-day performance has seen it change -44.81%. Over the past 30 days, the shares of Myriad Genetics, Inc (NASDAQ:MYGN) have changed -46.54%.
Wall Street analysts have a consensus price target for the stock at $12.5, which means that the shares’ value could jump 66.0% from current levels. The projected low price target is $6.0 while the price target rests at a high of $21.0. In that case, then, we find that the current price level is -394.12% off the targeted high while a plunge would see the stock gain -41.18% from current levels.
Myriad Genetics, Inc (MYGN) estimates and forecasts
The company’s shares have lost -75.81% over the past 6 months.
Earnings growth for 2025 is a modest -91.14% while over the next 5 years, the company’s earnings are expected to increase by 25.05%.
MYGN Dividends
Myriad Genetics, Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Myriad Genetics, Inc (NASDAQ:MYGN)’s Major holders
The top two institutional holders are BLACKROCK INC. with over 15.15 million shares worth more than $370.59 million. As of 2024-06-30, BLACKROCK INC. held 16.7227% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 10.06 million shares as of 2024-06-30. The firm’s total holdings are worth over $246.18 million and represent 11.1089% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD EXPLORER FUND . As of Mar 31, 2025 , the former fund manager holds about 6.11% shares in the company for having 5.63 shares of worth $23.92 million while later fund manager owns 3.29 shares of worth $14.0 million as of Jan 31, 2025 , which makes it owner of about 3.57% of company’s outstanding stock.
